Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country

被引：22
作者：
Birgand, G. [1 ,2 ]
Armand-Lefevre, L. [2 ,3 ]
Lepainteur, M. [1 ]
Lolom, I. [1 ]
Neulier, C. [1 ]
Reibel, F. [1 ]
Yazdanpanah, Y. [2 ,4 ]
Andremont, A. [2 ,3 ]
Lucet, J. C. [1 ,2 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Infect Control Unit, F-75877 Paris 18, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, IAME, UMR 1137, Paris, France
[3] Bichat Claude Bernard Hosp, Bacteriol Lab, F-75877 Paris 18, France
[4] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris 18, France
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2014年 / 20卷 / 11期
关键词：
Carbapenamase-producing Enterobacteriaceae; colonization; vglycopeptide-resistant enterococci; repatriation; ACINETOBACTER-BAUMANNII; FECAL CARRIAGE; EMERGENCE; ENTEROBACTERIACEAE; RISK;
D O I：
10.1111/1469-0691.12604
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We describe the prevalence of carriage and variables associated with introduction of highly drug-resistant microorganisms (HDRMO) into a French hospital via patients repatriated or recently hospitalized in a foreign country. The prevalence of HDRMO was 11% (15/132), with nine carbapenamase-producing Enterobacteriaceae, nine carbapenem-resistant Acinetobacter baumannii and six glycopeptide-resistant enterococci. Half of the admitted patients (63/132, 48%) were colonized with extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBLPE). Among the four episodes with secondary cases, three involved A.baumannii.
引用
收藏
页码：O887 / O890
页数：4
相关论文
共 13 条
  • [1] Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients
    Armand-Lefevre, Laurence
    Angebault, Cecile
    Barbier, Francois
    Hamelet, Emilie
    Defrance, Gilles
    Ruppe, Etienne
    Bronchard, Regis
    Lepeule, Raphael
    Lucet, Jean-Christophe
    El Mniai, Assiya
    Wolff, Michel
    Montravers, Philippe
    Plesiat, Patrick
    Andremont, Antoine
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (03) : 1488 - 1495
  • [2] Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs
    Birgand, Gabriel
    Ruimy, Raymond
    Schwarzinger, Michael
    Lolom, Isabelle
    Bendjelloul, Gisele
    Houhou, Nadira
    Armand-Lefevre, Laurence
    Andremont, Antoine
    Yazdanpanah, Yazdan
    Lucet, Jean-Christophe
    [J]. ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2013, 2
  • [3] European Center for Disease Prevention And Control, 2012, ANT RES INT DAT EARS
  • [4] Glasner C, 2013, Euro Surveill, V18, DOI 10.2807/1560-7917.ES2013.18.28.20525
  • [5] Haut Conseil de la sante publique, PREV TRANSM CROIS BA
  • [6] Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
    Kempf, Marie
    Rolain, Jean-Marc
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (02) : 105 - 114
  • [7] Risk of Highly Resistant Bacteria Importation from Repatriates and Travelers Hospitalized in Foreign Countries: About the French Recommendations to Limit Their Spread
    Lepelletier, Didier
    Andremont, Antoine
    Grandbastien, Bruno
    [J]. JOURNAL OF TRAVEL MEDICINE, 2011, 18 (05) : 344 - 351
  • [8] The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
    Nordmann, Patrice
    Cuzon, Gaelle
    Naas, Thierry
    [J]. LANCET INFECTIOUS DISEASES, 2009, 9 (04) : 228 - 236
  • [9] Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors
    Ostholm-Balkhed, Ase
    Tarnberg, Maria
    Nilsson, Maud
    Nilsson, Lennart E.
    Hanberger, Hakan
    Hallgren, Anita
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (09) : 2144 - 2153
  • [10] Acinetobacter baumannii:: Emergence of a successful pathogen
    Peleg, Anton Y.
    Seifert, Harald
    Paterson, David L.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (03) : 538 - 582
12